Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support
about
Plasma acylcarnitines are associated with pulmonary hypertension.Metabolomic profiling in patients undergoing Off-Pump or On-Pump coronary artery bypass surgery.Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.Direct infusion mass spectrometry for metabolomic phenotyping of diseases.Selecting heart failure patients for metabolic interventions.Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized MedicinePlasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues.Acute and long-term administration of palmitoylcarnitine induces muscle-specific insulin resistance in mice.Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.Metabolomic profile of arterial stiffness in aged adults.Metabolic Biomarkers in Heart Failure.Interventional Left Atrial Appendage Closure Affects the Metabolism of Acylcarnitines.Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients.Cardiovascular Metabolomics.Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.Dissecting Clinical and Metabolomics Associations of Left Atrial Phasic Function by Cardiac Magnetic Resonance Feature Tracking.
P2860
Q33738636-13649338-4B0F-4261-B0B1-C2F94DA84466Q36337156-B73B1E42-31F2-428F-BB9D-D7AD26EA754EQ37240351-EA38D53C-3611-4A63-940A-E66C580F020EQ39030360-BF6E7E22-1C3A-4C33-8EFD-B7BAD9BD2D13Q42067098-71CB3C11-E98F-4AB6-8DDB-79BCD7400C11Q42333907-06CABF99-8B5B-46EB-9D5F-70735C9226F7Q47108610-E79DAD96-08AE-4492-AB65-73AB5614A24FQ48056861-3CC2E397-A2AA-4F7D-8528-30A7EE59C1BCQ49331990-C7952CD0-59E4-4571-8BC3-0060E4E45758Q49618407-E866A818-F823-489B-A8C3-33F248D700BDQ49888514-B92A326E-C069-4EF7-90EB-FEA5AAD95A06Q50133651-40C66395-8DE1-48EA-A8BA-FA0C4E311511Q51252064-8B7B8090-650F-49F3-8963-F363429D6B49Q52560349-60138721-E462-4CE5-9CB3-7CCD437B55E1Q52575994-754DABFA-EB91-45C3-8608-7250409D1A50Q55257706-3A3793AA-6729-434A-8DDD-0F71C4C46489
P2860
Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Prognostic Implications of Lon ...... Mechanical Circulatory Support
@ast
Prognostic Implications of Lon ...... Mechanical Circulatory Support
@en
type
label
Prognostic Implications of Lon ...... Mechanical Circulatory Support
@ast
Prognostic Implications of Lon ...... Mechanical Circulatory Support
@en
prefLabel
Prognostic Implications of Lon ...... Mechanical Circulatory Support
@ast
Prognostic Implications of Lon ...... Mechanical Circulatory Support
@en
P2093
P2860
P1476
Prognostic Implications of Lon ...... Mechanical Circulatory Support
@en
P2093
Amanda Verma
Anne S Hellkamp
Carmelo A Milano
Chetan B Patel
Dawn E Bowles
G Michael Felker
Jacob P Kelly
Jeffrey M Testani
Joseph G Rogers
Marc D Samsky
P2860
P304
P356
10.1016/J.JACC.2015.10.079
P407
P577
2016-01-01T00:00:00Z